Our product, OVA1, would provide gynecologists and other physicians with a new piece of data that could help determine the likelihood that a woman's ovarian mass was benign or malignant.

FORBES: Leadership

We were far along in our quest to develop a diagnostic test that can help gynecologists and other physicians determine the likelihood that a woman's ovarian mass is benign or malignant.

FORBES: Leadership

Instead of a probabilistic world where we are comfortable making decisions according to, say, the odds of thunderstorms ruining a picnic, we are thrust into binary hell, where the choices and chances are only two: win or lose, white or black, benign or malignant.

FORBES: 1st Person | Facing an Unsettled Future After Radiation Exposure